← Back to Patent Explorer
US4792448A Expired / Lapsed US ⏱️ 0.0 years remaining

Generic zero order controlled drug delivery system

Assignee: Pfizer Inc
•
Filing: 1987-06-11
•
Granted: 1988-12-20
•
Expires: 2007-06-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A device for zero order releasing of biologically active substances into a fluid medium comprising a cylindrical tablet or bolus covered with an impermeable wall or coating from which strips of said wall or coating have been removed.

Inventors

  • 👤 Gautam R. Ranade

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 01:42
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0053; A61K9/0068; A61K9/20; A61K9/2072; A61L; A61L9/00; A61L9/015; A61L9/04; A61L9/05

Claims Analysis

Total Claims: 35
Claim 1
Independent Claim 74 words
A device for the controlled release of one or more active substances into a fluid medium at a substantially constant rate which comprises said substance homogeneously dispersed, with or without one or more inert excipients, and contained substantially in the shape of a cylindrical tablet or bolus by means of an all-covering essentially impermeable wall or coating except for one or more strips of removed wall or coating from the side of said device.
Claim 2
Independent Claim 74 words
A device for the controlled release of one or more active substances into a fluid medium at a substantially constant rate which comprises said substance homogeneously dispersed, with or without one or more inert excipients, and contained substantially in the shape of a cylindrical tablet or bolus by means of an all-covering essentially impermeable wall or coating except for one or more strips of removed wall or coating from the side of said device.
Claim 3
Dependent Claim 17 words
A device of claim 1, wherein the side is flat and the top and bottom are convex.
Claim 4
Dependent Claim 22 words
A device of claim 2, wherein more than one strip of wall or coating is removed from the side of said device.
Claim 5
Dependent Claim 21 words
A device of claim 3, wherein the width of said removed strips can be the same or different from each other.
Claim 6
Dependent Claim 16 words
A device of claim 4, wherein the device is in the shape of a cylindrical tablet.
Claim 7
Dependent Claim 15 words
A device of claim 4, wherein the device is in the shape of a bolus.
Claim 8
Dependent Claim 11 words
A device of claim 1, wherein the substance is biologically active.
Claim 9
Dependent Claim 21 words
A device of claim 7, wherein the activity is to prevent or reduce odors in or emanating from the fluid medium.
Claim 10
Dependent Claim 11 words
A device of claim 7, wherein the substance has germicidal activity.
Claim 11
Dependent Claim 11 words
A device of claim 7, wherein the substance has pharmacological activity.
Claim 12
Dependent Claim 90 words
A bolus for oral administration into the reticulum or rumen of a ruminant mammal, said bolus being retained in said rumen or reticulum and releasing one or more active substances into the environment of said rumen or reticulum at a substantially constant rate over a prolonged period of time, which comprises said active agent or substances homogeneously dispersed in a matrix and contained by means of an all-covering essentially impermeable wall or coating except for one or more strips of removed wall or coating from the side of said bolus.
Claim 13
Dependent Claim 90 words
A bolus for oral administration into the reticulum or rumen of a ruminant mammal, said bolus being retained in said rumen or reticulum and releasing one or more active substances into the environment of said rumen or reticulum at a substantially constant rate over a prolonged period of time, which comprises said active agent or substances homogeneously dispersed in a matrix and contained by means of an all-covering essentially impermeable wall or coating except for one or more strips of removed wall or coating from the side of said bolus.
Claim 14
Dependent Claim 21 words
A bolus of claim 11, wherein the active substance is morantel or a pharmaceutically acceptable salt thereof in a polymer matrix.
Claim 15
Dependent Claim 76 words
A tablet for oral administration to a mammal which releases a pharmaceutically active substance into the fluid of the gastrointestinal tract of said mammal at a substantially constant rate over an appreciable time interval which comprises said substance homogeneously dispersed, with or without one or more pharmaceutically-acceptable excipients and contained by means of an all-covering impermeable wall or coating except for one or more strips of removed wall or coating from the side of said tablet.
Claim 16
Dependent Claim 76 words
A tablet for oral administration to a mammal which releases a pharmaceutically active substance into the fluid of the gastrointestinal tract of said mammal at a substantially constant rate over an appreciable time interval which comprises said substance homogeneously dispersed, with or without one or more pharmaceutically-acceptable excipients and contained by means of an all-covering impermeable wall or coating except for one or more strips of removed wall or coating from the side of said tablet.
Claim 17
Dependent Claim 11 words
A tablet of claim 13, wherein the substance is an antihypertensive.
Claim 18
Dependent Claim 10 words
A tablet of claim 14, wherein the substance is prazosin.
Claim 19
Dependent Claim 10 words
A tablet of claim 14, wherein the substance is nifedipine.
Claim 20
Dependent Claim 10 words
A tablet of claim 14, wherein the substance is trimazosin.
Claim 21
Dependent Claim 10 words
A tablet of claim 14, wherein the substance is doxazosin.
Claim 22
Dependent Claim 12 words
A tablet of claim 13, wherein the substance is an antianxiety agent.
Claim 23
Dependent Claim 10 words
A tablet of claim 19, wherein the substance is hydroxyzine.
Claim 24
Dependent Claim 10 words
A tablet of claim 19, wherein the substance is sertraline.
Claim 25
Dependent Claim 11 words
A tablet of claim 13, wherein the substance is a bronchodilator.
Claim 26
Dependent Claim 10 words
A tablet of claim 22, wherein the substance is pirbuterol.
Claim 27
Dependent Claim 13 words
A tablet of claim 13, wherein the substance is a blood-glucose lowering agent.
Claim 28
Dependent Claim 10 words
A tablet of claim 24, wherein the substance is glipizide.
Claim 29
Dependent Claim 14 words
A tablet of claim 13, wherein the substance is a cough or cold agent.
Claim 30
Dependent Claim 11 words
A tablet of claim 26, wherein the substance is brompheniramine maleate.
Claim 31
Dependent Claim 11 words
A tablet of claim 26, wherein the substance is chlorpheniramine maleate.
Claim 32
Dependent Claim 11 words
A tablet of claim 26, wherein the substance is phenylephrine hydrochloride.
Claim 33
Dependent Claim 11 words
A tablet of claim 26, wherein the substance is pseudoephedrine hydrochloride.
Claim 34
Dependent Claim 10 words
A tablet of claim 26, wherein the substance is cetirizine.
Claim 35
Dependent Claim 11 words
A tablet of claim 26, wherein the substance is dexbrompheniramine maleate.

References Cited (Backward Citations)

US3851648A Cited
US4690824A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-12-20 1992-06-20 1992-12-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-12-20 1996-06-20 1996-12-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-12-20 2000-06-20 2000-12-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag